Entry
D06655 Drug Name
Tesamorelin (USAN) Formula
C221H366N72O67S Exact mass
5132.7166 Mol weight
5135.78 Sequence
C6H9O-Tyr Ala Asp Ala Ile Phe Thr Asn Ser Tyr Arg Lys Leu Gly Gln Leu Ser Ala Arg Lys Leu Leu Gln Asp Ile Met Ser Arg Gln Gln Gly Glu Ser Asn Gln Glu Arg Gly Ala Arg Ala Arg Leu-NH2 Type
Peptide Remark
ATC code: H01AC06
Chemical structure group: DG00495
Product (DG00495): D09015<US> Efficacy
Growth hormone releasing hormone receptor agonist Comment
growth hormone-releasing hormone (GH-RH) [HSA:2691] [KO:K05260] analog For reduction of visceral adipose tissue in patients receiving antiretroviral therapy Target
GHRHR [HSA:2692] [KO:K04584] Pathway
hsa04080 Neuroactive ligand-receptor interaction Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303] H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS H01 PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES H01A ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES H01AC Somatropin and somatropin agonists H01AC06 Tesamorelin D06655 Tesamorelin (USAN) Target-based classification of drugs [BR:br08310] G Protein-coupled receptors Secretin receptor family Growth hormone-releasing hormone GHRHR D06655 Tesamorelin (USAN) Other DBs
CAS: 218949-48-5
PubChem: 47208306
ChEBI: 63626